Embedded Files
Please join our community on Facebook
You can also email us at: bluenevusmelanoma@gmail.com
If you are someone you love has been diagnosed with blue nevus melanoma, consider filing out the following Patient Registry. Such Patient Registry will allow us to contact you if we hear of interesting clinical trials, share with you information on relevant educational events, as well as share de-identified data with partners interested in developing new drugs to treat blue nevus melanoma.
Our Board
Vern Norviel serves as President of the Board. Vern has served the biotech community for the last 40+ years in various capacities including as an inventor, investor, founder, business and legal advisor, educator, and philanthropist.
Ariela Tannenbaum serves as Treasurer of the Board. Ariela has spent 30+ years providing financial support to companies in the life sciences, legal services, and financial industries.
Maya Skubatch serves as Secreatery of the Board. Maya has worked in the life science legal space for 25+ years. She advocates vociferously for her clients and is passionate about improving wellness, health span, and therapeutic access to all.
Our Advisors
Joy Cavagnaro is President of Access BIO where she consults on development strategies and therapeutic safety for novel drug, biologics and device combinations. During her tenure at CBER/FDA she was appointed to the Senior Biomedical Research Service and served as FDA’s safety topic lead and rapporteur for “ICH S6.” She was the first to advocate the “case-by-case” science based approach to preclinical safety evaluation.
Dr. Cassian Yee is a Professor in the Department of Melanoma Medical Oncology and Department of Immunology at the University of Texas MD Anderson Cancer Center where he is also Director of the Solid Tumor Cell Therapy Program. He is the founder of Mongoose Bio is a TCR-T cell therapy company using epigenetically programmed memory T cells targeting first-in-class immunogenic epitopes for common and rare cancers.
Dr. Boris Bastian is a Gerson and Barbara Bakar Distinguished Professor of Cancer Biology at UCSF. He is a faculty member of the Dermatopathology Division of the Departments of Dermatology and Pathology and oversees its molecular diagnostic laboratory. He also founded and directed the Clinical Cancer Genomics Laboratory at UCSF, which performs molecular diagnostics for UCSF cancer patients. His NIH-funded research laboratory focuses on the molecular genetics of cutaneous neoplasms, with a particular emphasis on the discovery of genetic alterations useful for diagnosis, classification, and therapy.
Would you like to join our team? It takes a village to solve hard problems. All and any help is welcomed!
Page updated
Google Sites
Report abuse